Published in J Thromb Haemost on September 01, 2006
Statins to Reduce D-dimer Levels in Patients With Venous Thrombosis | NCT00437892
Venous thromboembolism in patients with membranous nephropathy. Clin J Am Soc Nephrol (2011) 2.18
Venous and arterial thrombosis: Two aspects of the same disease? Clin Epidemiol (2009) 1.05
Venous thromboembolism and atherosclerosis: common denominators or different diseases? J Thromb Haemost (2006) 1.02
Incident venous thromboembolic events in the Prospective Study of Pravastatin in the Elderly at Risk (PROSPER). BMC Geriatr (2011) 0.78
Venous thromboembolism has the same risk factors as atherosclerosis: A PRISMA-compliant systemic review and meta-analysis. Medicine (Baltimore) (2016) 0.77
Three months versus one year of oral anticoagulant therapy for idiopathic deep venous thrombosis. Warfarin Optimal Duration Italian Trial Investigators. N Engl J Med (2001) 3.07
Recommendation on the nomenclature for oral anticoagulants: communication from the SSC of the ISTH. J Thromb Haemost (2015) 2.19
Clinical experience with retrievable vena cava filters: results of a prospective observational multicenter study. J Thromb Haemost (2005) 2.18
Anticoagulant therapy for venous thromboembolism during pregnancy: a systematic review and a meta-analysis of the literature. J Thromb Haemost (2013) 2.15
The predictive ability of bleeding risk stratification models in very old patients on vitamin K antagonist treatment for venous thromboembolism: results of the prospective collaborative EPICA study. J Thromb Haemost (2013) 2.05
Incidence of cancer after a first episode of idiopathic venous thromboembolism treated with 3 months or 1 year of oral anticoagulation. J Thromb Haemost (2003) 1.95
Diagnostic accuracy of D-dimer test for exclusion of venous thromboembolism: a systematic review. J Thromb Haemost (2006) 1.69
Incidence and predictors of bleeding or thrombosis after polypectomy in patients receiving and not receiving anticoagulation therapy. J Thromb Haemost (2009) 1.68
The metabolic syndrome and the risk of venous thrombosis: a case-control study. J Thromb Haemost (2006) 1.55
Clinical review: Thyroid dysfunction and effects on coagulation and fibrinolysis: a systematic review. J Clin Endocrinol Metab (2007) 1.32
Prevalence and clinical history of incidental, asymptomatic pulmonary embolism: a meta-analysis. Thromb Res (2010) 1.18
Measuring Oral Direct Inhibitors (ODIs) of thrombin and factor Xa: A recommendation from the Subcommittee on Control of Anticoagulation of the Scientific and Standardisation Committee of the International Society on Thrombosis and Haemostasis. J Thromb Haemost (2013) 1.16
A case report and literature review of portal vein thrombosis associated with cytomegalovirus infection in immunocompetent patients. Clin Infect Dis (2006) 1.14
Treatment of coumarin-associated coagulopathy: a systematic review and proposed treatment algorithms. J Thromb Haemost (2006) 1.11
Meta-analysis of the efficacy and safety of new oral anticoagulants in patients with cancer-associated acute venous thromboembolism: comment. J Thromb Haemost (2014) 1.05
Long-term outcomes of patients with cerebral vein thrombosis: a multicenter study. J Thromb Haemost (2012) 0.99
Systematic review on the effect of glucocorticoid use on procoagulant, anti-coagulant and fibrinolytic factors. J Thromb Haemost (2010) 0.97
D-dimer testing in the diagnosis of cerebral vein thrombosis: a systematic review and a meta-analysis of the literature. J Thromb Haemost (2012) 0.96
Low-dose aspirin for in vitro fertilization or intracytoplasmic sperm injection: a systematic review and a meta-analysis of the literature. J Thromb Haemost (2012) 0.96
Twelve-month outcomes and predictors of very stable INR control in prevalent warfarin users. J Thromb Haemost (2010) 0.94
Incidence of arterial cardiovascular events after venous thromboembolism: a systematic review and a meta-analysis. J Thromb Haemost (2010) 0.93
Antithrombotic and fibrinolytic drugs for retinal vein occlusion: a systematic review and a call for action. Thromb Haemost (2009) 0.92
Prothrombin complex concentrates for urgent anticoagulation reversal in patients with intracranial haemorrhage. Pathophysiol Haemost Thromb (2009) 0.89
Hypothyroidism and acquired von Willebrand's syndrome: a systematic review. Haemophilia (2008) 0.89
Alterations in coagulation and fibrinolysis after levothyroxine exposure in healthy volunteers: a controlled randomized crossover study. J Thromb Haemost (2011) 0.88
Clopidogrel plus aspirin versus aspirin alone for preventing cardiovascular disease. Cochrane Database Syst Rev (2007) 0.88
Diagnostic accuracy of lung ultrasound for pulmonary embolism: a systematic review and meta-analysis. J Thromb Haemost (2013) 0.87
Cerebral vein and sinus thrombosis and hyperthyrodism: a case report and a systematic review of the literature. Thromb Res (2011) 0.87
Outpatient treatment and early discharge of symptomatic pulmonary embolism: a systematic review. Eur Respir J (2009) 0.86
Incidental diagnosis of a deep vein thrombosis in consecutive patients undergoing a computed tomography scan of the abdomen: a retrospective cohort study. J Thromb Haemost (2012) 0.85
Optimal treatment duration of venous thrombosis. J Thromb Haemost (2013) 0.84
Association between inherited thrombophilic abnormalities and central venous catheter thrombosis in patients with cancer: a meta-analysis. J Thromb Haemost (2007) 0.84
Prognostic relevance of an asymptomatic venous thromboembolism in patients with cancer. J Thromb Haemost (2011) 0.83
Is venous thromboembolism more frequent in patients with obstructive sleep apnea syndrome? J Thromb Haemost (2004) 0.82
Abdominal obesity and the risk of recurrent deep vein thrombosis. Thromb Res (2006) 0.82
Low dose oral vitamin K to reverse acenocoumarol-induced coagulopathy: a randomized controlled trial. Thromb Haemost (2002) 0.81
Prognostic clinical prediction rules to identify a low-risk pulmonary embolism: a systematic review and meta-analysis. J Thromb Haemost (2012) 0.81
Autonomic function and baroreflex sensitivity during a normal ovulatory cycle in humans. Acta Cardiol (1999) 0.80
Risk of recurrence of unusual site venous thromboembolism. Hamostaseologie (2013) 0.80
Thalassemia trait and arterial thromboembolic events: a systematic review and a meta-analysis of the literature. J Thromb Haemost (2011) 0.80
The diagnosis of symptomatic recurrent pulmonary embolism and deep vein thrombosis: guidance from the SSC of the ISTH. J Thromb Haemost (2013) 0.79
Decreased active von Willebrand factor level owing to shear stress in aortic stenosis patients. J Thromb Haemost (2011) 0.79
Poor predictive value of contemporary bleeding risk scores during long-term treatment of venous thromboembolism. A multicentre retrospective cohort study. Thromb Haemost (2014) 0.79
Acquired von Willebrand syndrome in patients with overt hypothyroidism: a prospective cohort study. Haemophilia (2013) 0.79
Predictors of residual venous obstruction after deep vein thrombosis of the lower limbs: a prospective cohort study. Thromb Res (2002) 0.79
Efficacy of low molecular weight heparin in patients undergoing in vitro fertilization or intracytoplasmic sperm injection. J Thromb Haemost (2011) 0.78
Long-duration therapy with low molecular weight heparin in patients with antiphospholipid antibody syndrome resistant to warfarin therapy. J Thromb Haemost (2005) 0.78
Prevalence of arterial and venous thromboembolic events in diabetic patients with and without the metabolic syndrome: a cross sectional study. Thromb Res (2011) 0.78
The coagulation system in endocrine disorders: a narrative review. Intern Emerg Med (2007) 0.77
Single intravenous administration of TB-402 for the prophylaxis of venous thromboembolism after total knee replacement: a dose-escalating, randomized, controlled trial. J Thromb Haemost (2011) 0.77
Antiplatelet drugs for polycythaemia vera and essential thrombocythaemia. Cochrane Database Syst Rev (2008) 0.76
Do Italian vascular centers look for isolated calf deep vein thrombosis? Analysis of isolated calf deep vein thromboses included in the ''Master'' Registry. Int Angiol (2008) 0.76
Pulmonary embolism severity index accurately predicts long-term mortality rate in patients hospitalized for acute pulmonary embolism. J Thromb Haemost (2013) 0.76
The effect of thyroid autoantibodies on warfarin stability. Thromb Res (2009) 0.75
Postoperative pericardial effusion in patients receiving anticoagulants for deep vein thrombosis after coronary artery bypass graft surgery. J Thromb Haemost (2005) 0.75
Anticoagulant therapy for venous thromboembolism during pregnancy: a systematic review and a meta-analysis of the literature: a reply to a rebuttal. J Thromb Haemost (2013) 0.75
The association between neonatal ABO blood group and intraventricular hemorrhage in extremely low birth weight infants: a reply to a comment. J Thromb Haemost (2013) 0.75
Retinal vein thrombosis: pathogenesis and management: a rebuttal. J Thromb Haemost (2011) 0.75
The predictive ability of bleeding risk stratification models in very old patients on vitamin K antagonist treatment for venous thromboembolism: results of the prospective collaborative EPICA study: reply. J Thromb Haemost (2014) 0.75
Prophylaxis of venous thromboembolism following laparoscopic surgery: where is the evidence? J Thromb Haemost (2005) 0.75
Fibrin clot structure and fibrinolysis in hypothyroid individuals: the effects of normalising thyroid hormone levels. J Thromb Haemost (2012) 0.75
Mortality due to pulmonary embolism, myocardial infarction, and stroke among incident dialysis patients: a rebuttal. J Thromb Haemost (2013) 0.75
JAK2V617F mutation in patients with arterial thrombosis in the absence of overt myeloproliferative disease. J Thromb Haemost (2009) 0.75
Safety of fondaparinux in the prevention of venous thromboembolism in elderly medical patients: results of a single-center, retrospective study. Minerva Med (2014) 0.75
Emergency reversal of anticoagulation with vitamin K antagonists with 3-factor prothrombin complex concentrates in patients with major bleeding. J Thromb Thrombolysis (2013) 0.75
Management of primary care patients with suspected deep vein thrombosis: use of a therapeutic dose of low-molecular-weight heparin to avoid urgent ultrasonographic evaluation. J Thromb Haemost (2006) 0.75
The effects of an extremely high dose of levothyroxine on coagulation and fibrinolysis. J Thromb Haemost (2010) 0.75
Risk factors for suboptimal efficacy of 3-factor prothrombin complex concentrates in emergency VKA anticoagulation reversal. Thromb Haemost (2014) 0.75
Role of factor V Leiden or G20210A prothrombin mutation in patients with symptomatic pulmonary embolism and deep vein thrombosis: a meta-analysis of the literature. J Thromb Haemost (2012) 0.75
Venous thrombosis: A possible complication of overt hyperthyroidism. Eur J Intern Med (2007) 0.75
Imaging for the diagnosis of pulmonary embolism in very obese patients; a survey among internists and radiologists in Italy and the Netherlands. Thromb Res (2013) 0.75